![](/img/cover-not-exists.png)
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C
Avidan U. Neumann, Stephen Pianko, Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Moshe Mishan, John G. McHutchison, Erik Pulkstenis, G. Mani SubramanianVolume:
51
Year:
2009
Language:
english
DOI:
10.1016/j.jhep.2009.01.017
File:
PDF, 1.77 MB
english, 2009